individualized medication guidance program-尊龙凯时

research technology and solutions

homeblood disease and transplantation immune disease detection technology programindividualized medication guidance program

individualized medication guidance program

chemotherapy drug gene detection

through the detection of blood tumor chemotherapy drugs, the selection of appropriate drugs and doses, the optimization of clinical treatment programs to provide reference, and strive to accurately locate, accurate drug delivery, and ultimately achieve better therapeutic results.

cstb uses a generation of sequencing methods to detect blood tumor chemotherapy drugs, including 27 kinds of chemotherapy drugs such as tacrolimus, cyclosporine, fluorouracil, and ibidaxin, with high accuracy and high speed.

immunosuppressant blood concentration detection

through advanced pharmaceutical analysis methods to detect the concentration of drugs and their metabolites in the blood, combined with pharmacokinetic principles and data analysis, explore the range of blood drug concentrations, develop individualized drug delivery programs to improve efficacy (avoid or reduce toxic side effects) at the same time, it provides important evidence for the diagnosis and treatment of drug overdose and the patient's medication compliance, and finally achieves the purpose of safe, effective and rational drug use.

cstb used high performance liquid chromatography-mass spectrometry (hplc-ms) to detect the plasma concentrations of cyclosporine a, tacrolimus, sirolimus, and everolimus. the method requires small sample size, simple sample preparation, short detection time, strong specificity, high sensitivity, low detection limit and high accuracy, and quantitative analysis of various substances of biological matrix; data reporting speed and high accuracy ,high quality.

hcmv resistance mutation

cstb uses nested pcr generation sequencing to detect mutations in hcmv ul97 and hcmv ul54 resistance genes, and the results are more accurate.

research and technical services

hematology micm diagnostic system hematopoietic stem cell transplantation donor selection dynamic monitoring program after hematopoietic stem cell transplantation individualized medication guidance program blood system disease gene decoding organ transplantation

shenzhen headquarters

address: building a17, life science industrial park, kwai chung street, dapeng new district, shenzhen

shanghai headquarters

address: building 21, phase 4, shanghai international medical park